Nav: Home

How two or more trips to the bathroom at night cost the US economy $44.4 billion a year

March 11, 2019

A new study has found that frequent visits to the bathroom at night could cost the US economy $44.4 billion a year. According to researchers at the not-for-profit research organisation RAND Europe, waking up more than twice a night due to nocturia, a health condition that affects the lower urinary tract, can have a detrimental effect on a person's wellbeing and productivity at work, which in turn has an impact on a country's GDP.

People who wake up at least twice a night to go to the toilet are more likely to be absent from work due to sickness or be less productive at work, as the disrupted night's sleep affects their ability to function during the day. The study's findings suggest that a person suffering with nocturia loses on average at least seven more working days a year due to absenteeism and presenteeism (being in suboptimal health while at work) than a person who does not have nocturia.

The number of people in the US workforce estimated to suffer with nocturia is 27.5 million, 12.5 per cent of the total working population. In the five other countries included in the economic analysis of the report - the UK, Germany, Spain, Japan and Australia - an additional 53.6 million people could have nocturia, ranging from 13 per cent to 17 per cent of the population of each country.

The economic losses (in GDP terms) associated with nocturia are estimated to be about $13.7 billion in Japan, followed by Germany at $8.4 billion, the UK at $5.9 billion, and Spain and Australia each at about $3 billion.

Researchers used a unique macroeconomic model to simulate the current economic situation of each of the six countries under consideration and then predicted how economic output would be affected, if the proportion of people suffering with nocturia in the economy were reduced.

People suffering with nocturia also reported lower life satisfaction and work engagement, according to data collected through two large, linked employer-employee surveys (see below). On average, a person with nocturia has a 2 per cent lower life satisfaction compared to a person not suffering with nocturia. This association is similar to if the individual suffered from other serious health conditions such as hypertension, cardiovascular disease or asthma.

Furthermore, people suffering with nocturia have a 1.3 per cent lower engagement at work compared to people not suffering from the condition. This is similar to people with chronic conditions like kidney disease or hypertension.

Marco Hafner, lead researcher and senior economist says: "Doctors and health practitioners often overlook nocturia as a potential health problem associated with sleep loss, and patients can delay reporting the condition until it becomes unbearable and substantially affects their wellbeing.

"Given the substantial economic implications of untreated nocturia, this should be a 'wake-up' call to diverse stakeholders, including patients, health-care providers and employers, of the importance of identifying and treating nocturia."

A variety of demographic, lifestyle and health factors are associated with nocturia and they differ by age and gender. The study found that chronic health conditions such as kidney disease, diabetes, cardiovascular disease, cancer and hypertension could all play a role.
This independent research was prepared for Ferring Pharmaceuticals. To view the full report, How frequent night-time bathroom visits can negatively impact sleep, wellbeing and productivity, or arrange an interview with one of the researchers on the project please contact Cat McShane via the details attached.
  • Nocturia is a lower urinary tract condition representing the complaint of individuals having to wake up at night one or more times to void, where each void is preceded and followed by sleep. There are multiple types of nocturia, among the most frequent being a large urine volume produced during the night (nocturnal polyuria) or a reduced bladder capacity. Nocturia, defined as at least two night-time voids, is relatively common, affecting on average about 20 per cent of the overall population, with prevalence increasing with age.
  • The study is partially based on workplace survey data collected through two large, linked employer-employee datasets by Vitality UK, part of the Discovery Group, and AIA, covering the countries UK, Australia, Malaysia, Hong Kong, Singapore, Thailand, and Sri Lanka.
  • RAND Europe is a not-for-profit research organisation whose mission is to help improve policy and decision making through research and analysis

RAND Corporation

Related Cardiovascular Disease Articles:

Is educational attainment associated with lifetime risk of cardiovascular disease?
Men and women with the lowest education level had higher lifetime risks of cardiovascular disease than those with the highest education level, according to a new study published by JAMA Internal Medicine.
Food policies could lower US cardiovascular disease rates
New research conducted by the University of Liverpool and partners shows that food policies, such as fruit and vegetable subsidies, taxes on sugar sweetened drinks, and mass media campaigns to change dietary habits, could avert hundreds of thousands of deaths from cardiovascular disease (CVD) in the United States.
Cardiovascular disease causes one-third of deaths worldwide
Cardiovascular diseases (CVD), including heart diseases and stroke, account for one-third of deaths throughout the world, according to a new scientific study that examined every country over the past 25 years.
Kidney disease is a major cause of cardiovascular deaths
In 2013, reduced kidney function was associated with 4 percent of deaths worldwide, or 2.2 million deaths.
Cardiovascular disease costs will exceed $1 trillion by 2035
A new study projects that by 2035, cardiovascular disease, the most costly and prevalent killer, if left unchecked, will place a crushing economic and health burden on the nation's financial and health care systems.
Prescribing drugs for cardiovascular disease prevention in the UK
Drugs such as statins that have the potential to prevent strokes and other types of cardiovascular disease have not been prescribed to a large proportion of people at risk in the UK, according to a research article by Grace Turner of the University of Birmingham, Birmingham, UK and colleagues published in PLOS Medicine.
Fatty liver disease contributes to cardiovascular disease and vice versa
For the first time, researchers have shown that a bi-directional relationship exists between fatty liver disease and cardiovascular disease.
More dietary calcium may lower risk of cardiovascular disease
In older people, higher dietary calcium intake may lower the risk of cardiovascular disease, but not of stroke and fracture, new research from South Korea suggests.
Renal hemodynamics and cardiovascular function in health and disease
The SRC will focus on unpublished work that is state-of-the-art in study of cardiovascular and renal disease and hypertension.
Cardiovascular disease in adult survivors of childhood cancer
For adult survivors of childhood cancer, cardiovascular disease presents at an earlier age, is associated with substantial morbidity, and is often asymptomatic.

Related Cardiovascular Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".